Private Equity
Andrea Alms Video: Money In Motion 154 - Cell Therapy Manufacturing Market
April 2025 - Private Equity
Andrea Alms Video: Money in Motion 154 - Cell Therapy Manufacturing Market
TRANSCRIPT: Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion. What is it? The cell therapy manufacturing market is experiencing a substantial growth, driven by increasing demand for cell therapies and advancements in manufacturing technologies. It is the process of creating cell therapy for clinical use, involving isolating, modifying, expanding, and formulating cells in a controlled environment.
One model for manufacturing cell therapies is the centralized site is responsible for the production of cell therapy products, which are then delivered to the clinical site for use. Alternatively, two centralized manufacturing models that have included strategies for cell production and processing at point of care, and various instruments involving an environmentally controlled, validated manufacturing of cell therapies by the bedside.
Hence, the the near patient manufacturing model at towards health care. The global market was 5.27 billion in 2024, estimated to be 23.27 billion by 2034, growing at a compound average growth rate of 16%. At roots analysis, the market was 4.9 billion in 2020, form projected to be 13.83 billion by 2035 at a growth rate of 9.9%. At precedence research, the market was 4.83 billion in 2024 and expected to reach 18.89 billion in 2034, at a growth rate of 14.61%. Averaging the averages, the market is 5 billion at 13.5% growth rate. Thank you. This is your money. Your money in motion.